Immediate Impact
18 standout
Citing Papers
EASL Clinical Practice Guidelines on the management of hepatitis B virus infection
2025 Standout
A review of the clinical efficacy of FDA-approved antibody‒drug conjugates in human cancers
2024 Standout
Works of Monia Capponi being referenced
THE BRAF INHIBITOR VEMURAFENIB PLUS RITUXIMAB PRODUCES A HIGH RATE OF DEEP AND DURABLE RESPONSES IN RELAPSED/REFRACTORY HAIRY CELL LEUKEMIA: UPDATED RESULTS OF A PHASE‐2 TRIAL
2019
Management of Hepatitis B Virus Reactivation in Patients with Hematological Malignancies Treated with Chemotherapy
2009
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Monia Capponi | 25 | 59 | 55 | 6 | 91 | |
| C Mussini | 13 | 30 | 62 | 7 | 91 | |
| Christina Ganesh | 20 | 63 | 44 | 5 | 112 | |
| Hannah K. Jackson | 13 | 41 | 39 | 8 | 99 | |
| Mary-Anne Kedda | 11 | 81 | 63 | 5 | 171 | |
| Nicola Alcorn | 22 | 24 | 27 | 6 | 199 | |
| Francesco Marincola | 11 | 67 | 55 | 5 | 185 | |
| A. Jin | 16 | 79 | 22 | 5 | 133 | |
| Makiko Koyabu | 16 | 77 | 113 | 7 | 205 | |
| Tomomi Hakoda | 32 | 81 | 119 | 7 | 170 | |
| G.B. Gaeta | 4 | 103 | 130 | 5 | 142 |
All Works
Loading papers...